Fulvestrant in treatment for metastatic breast cancer

Background. Metastatic breast cancer is still an incurable disease, and is currently regarded as a chronic process requiring longterm treatment with periodic therapy replacements. Hormonal therapy shows its therapeutic efficacy with less toxicity and a better quality of life for patients compared wi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: L. Yu. Vladimirova, I. L. Popova, N. A. Abramova, A. E. Storozhakova, N. M. Tikhanovskaya, K. A. Novoselova, A. A. L’yanova, L. A. Ryadinskaya, M. O. Ezhova, M. A. Teplyakova, L. K. Strakhov
Médium: Artigo
Jazyk:Russo
Vydáno: Remedium Group LLC 2019-12-01
Edice:Медицинский совет
Témata:
metastatic hormone-positive breast cancer
fulvestrant
hormonal therapy
adverse events
toxicity
On-line přístup:https://www.med-sovet.pro/jour/article/view/5157
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky